Healthy
Conditions
Keywords
Concurrent, muscle, glycogen, molecular
Brief summary
This is a randomized, counterbalanced crossover design, in which 14 male subjects will complete two experimental trials. Each trial will be separated by a minimum of at least 12 days (range: 12-30 days). The study aims to investigate the effects of low glycogen availability on skeletal muscle molecular response after a concurrent exercise day.
Detailed description
Two experimental exercise trials; a low carbohydrate (= LOW) and a high carbohydrate (= HIGH) trial. During both experimental days subjects will complete an continues submaximal cycling bout in the morning followed by a resistance exercise session in the early afternoon. During the LOW trial subjects will receive a low carbohydrate mixed meal, during the HIGH trial subjects will be provided with a high carbohydrate meal. In addition, on both experimental days subjects will receive adequate protein beverages. Lastly, protein will be provided post resistance exercise.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Male gender between 18 and 30 years of age * BMI between 18.5 - 25 kg/m2 * Participating in regular exercise training (at least 1 exercise session, and a maximum of 3 exercise session per week) * Used to different types of exercise (endurance, resistance and/or concurrent) * Willing to give blood samples * Willing to give muscle biopsies * No use of antibiotics during the study or in the past month * No drug use * Suitable veins for blood withdrawal * Registered by a general-practitioner * Consumption of alcohol beverages is less than 21 per week * No blood donor during the study * No vegetarian and willing to eat meat during the experimental days * Able to be present and participate at both test days and pre testing moments * Not employed, or intern, or working on thesis at the department of Human Nutrition at Wageningen University * Not participating in another scientific study (except EetMeetWeet) * Able to participate during the experimental days en pre tests * Able to speak Dutch
Exclusion criteria
* Medical condition that can interfere with the study outcome (i.e. cardiovascular disease, pulmonary disease, gluten intolerance) * Systolic blood pressure \>160 mmHg and/or diastolic blood pressure \>100 mmHg * Use of medications known to interfere with gene expression in the muscles (i.e. statins, fenofibrate) * Use of antithrombotic therapy (marcoumar, sintromitis). * Diagnosed diabetes mellitus type 1 or 2 * (Chronic) injuries of the locomotor system that can interfere with the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proteins involved in hypertrophy | 10 hours |
Countries
Netherlands